Jerusalem Artichoke (Helianthus tuberosus)

Jerusalem artichoke (Helianthus tuberosus) is a tuber rich in inulin, a fructan-type prebiotic fiber that resists digestion in the small intestine and is fermented by colonic bacteria into short-chain fatty acids. This fermentation process modulates gut microbiota composition and may attenuate postprandial blood glucose spikes by slowing carbohydrate absorption.

Origin & History

Jerusalem artichoke (Helianthus tuberosus) is a perennial plant native to North America, belonging to the sunflower family, with edible tubers rich in inulin, a type of fructan. The tubers are harvested from underground rhizomes and processed into powders or extracts using methods like ultrasound-assisted extraction with ethanol. As a member of the USDA Nutrient-Dense Foods category, it contains high levels of prebiotic inulin-type fructans alongside phenolic and flavonoid compounds.

Historical & Cultural Context

Jerusalem artichoke has been used in folk medicine for lowering cholesterol, triglycerides, and glucose, as well as for weight loss, detoxification from alcohol and heavy metals, and reducing uric acid. Traditional applications also include immunostimulation, gastric protection, constipation prevention, and supporting cardiovascular health, though these uses are not tied to specific traditional medicine systems like Ayurveda or TCM.

Health Benefits

• Supports blood sugar management - One RCT (n=60) showed reduced postprandial glucose in prediabetic and type 2 diabetic patients (moderate evidence)
• Acts as a prebiotic - High inulin content modulates gut microbiota and supports digestive health (preliminary animal evidence)
• Provides antioxidant protection - Tuber extracts regulate oxidative stress genes (SOD-1, Nox-4) and reduce ROS in cell studies (preliminary evidence)
• Reduces inflammation - Heliangin from leaves inhibits NF-κB signaling and excessive NO production in macrophages (preliminary in-vitro evidence)
• May support metabolic health - Extracts show lipase and α-amylase inhibition in laboratory studies (preliminary evidence)

How It Works

Jerusalem artichoke's primary bioactive, inulin (a β(2→1)-linked fructooligosaccharide polymer), bypasses small intestinal digestion and reaches the colon intact, where Bifidobacterium and Lactobacillus species ferment it into short-chain fatty acids—primarily butyrate, propionate, and acetate—that activate GPR41/GPR43 receptors to modulate glucose homeostasis and intestinal motility. Inulin also inhibits small intestinal sucrase-isomaltase activity, slowing disaccharide hydrolysis and reducing the rate of glucose entry into portal circulation. Additionally, chlorogenic acids and dicaffeoylquinic acid derivatives in the tuber inhibit alpha-glucosidase and alpha-amylase enzymes, providing a complementary glycemic-modulating mechanism.

Scientific Research

Human clinical evidence is limited to one randomized, double-blinded, placebo-controlled trial (PMID: 30026514) involving 60 subjects with impaired glucose metabolism who received 19.45g Jerusalem artichoke powder daily for 12 weeks, showing improvements in postprandial glucose and oxidative stress. Most other evidence comes from animal studies, including improved rumen health in calves (PMID: 40418100) and growth enhancement in tilapia (PMID: 36290267).

Clinical Summary

One randomized controlled trial (n=60 prediabetic and type 2 diabetic patients) demonstrated that Jerusalem artichoke supplementation significantly reduced postprandial blood glucose compared to placebo, representing moderate-quality evidence given its single-trial basis and moderate sample size. Animal studies and in vitro data consistently show inulin-driven increases in Bifidobacterium abundance and elevated fecal butyrate concentrations, though these findings have not been robustly replicated in large human trials. Antioxidant effects attributed to chlorogenic acid content remain at the preliminary stage, with no adequately powered human RCTs confirming clinical relevance. Overall, evidence is promising but limited; further trials with longer durations and larger cohorts are needed before strong efficacy conclusions can be drawn.

Nutritional Profile

Jerusalem artichoke tubers (per 100g raw) provide approximately 73-76 kcal, with carbohydrates as the dominant macronutrient (17-19g), of which inulin-type fructans comprise 14-19g (the primary storage carbohydrate, replacing starch). Protein content is moderate at 2.0-2.4g, with fat being negligible (<0.1g). Dietary fiber (non-inulin) contributes approximately 1.6g. Key micronutrients include potassium (429-637mg, one of the richest vegetable sources), iron (3.4-4.0mg, notably high though non-heme bioavailability is limited by phytates), phosphorus (78-117mg), magnesium (17mg), copper (0.14mg), and thiamine/B1 (0.20mg). Vitamin C is present at 4-6mg per 100g. Bioactive compounds include chlorogenic acid (the predominant phenolic, ~1.2-3.5mg/g dry weight), dicaffeoylquinic acids, flavonoids (luteolin, quercetin glycosides), and carotenoids in trace amounts. Inulin chain length (degree of polymerization: DP 3-60) influences prebiotic fermentation rate and colonic site of action; longer-chain inulin ferments more slowly in the distal colon. Inulin bioavailability as an energy source is low (~1.5 kcal/g) due to resistance to human amylases, with fermentation by Bifidobacterium and Lactobacillus species producing short-chain fatty acids (acetate, propionate, butyrate). Iron bioavailability is estimated at 5-12% due to concurrent phytate and oxalate content. Potassium is highly bioavailable. Raw consumption yields higher intact inulin; cooking (boiling, roasting) partially hydrolyzes inulin to fructose, increasing glycemic impact and reducing prebiotic effect.

Preparation & Dosage

The clinically studied human dosage is 19.45g of Jerusalem artichoke powder daily (mixed with fermented soybean) for 12 weeks. Animal studies have used 1-3% powder in basal diet for calves and 5-10g/kg diet in fish. No standardization for inulin content was specified in clinical studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fermented soybean, probiotics, chromium, cinnamon, alpha-lipoic acid

Safety & Interactions

Jerusalem artichoke is generally recognized as safe when consumed as food, but its high inulin content (up to 19 g per 100 g fresh weight) frequently causes dose-dependent gastrointestinal side effects including bloating, flatulence, and loose stools, particularly at intakes above 10 g of inulin per day. Individuals with fructose malabsorption or irritable bowel syndrome following a low-FODMAP diet should avoid concentrated supplements, as inulin is a high-FODMAP fermentable carbohydrate. Caution is warranted in patients taking antidiabetic medications such as metformin or insulin, as additive glucose-lowering effects may increase hypoglycemia risk, necessitating blood glucose monitoring. Safety data during pregnancy and lactation are insufficient; food-level consumption is likely safe, but concentrated supplement use is not recommended without medical supervision.